Request Deal Involvement

GreatPoint Ventures led a $60m funding round in Excision BioTherapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Burns McClellan

pr advisors

Burns McClellan

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

ANZU PARTNERS

bidder

ANZU PARTNERS

EXCISION BIOTHERAPEUTICS

target

EXCISION BIOTHERAPEUTICS

NORWEST VENTURE PARTNERS

bidder

NORWEST VENTURE PARTNERS

COTA CAPITAL

bidder

COTA CAPITAL

OLIVE TREE CAPITAL VENTURES

bidder

OLIVE TREE CAPITAL VENTURES

LOREDA HOLDINGS

bidder

LOREDA HOLDINGS

ADJUVANT CAPITAL

bidder

ADJUVANT CAPITAL

INDUSAGE PARTNERS

bidder

INDUSAGE PARTNERS

GREATPOINT VENTURES

bidder

GREATPOINT VENTURES

ARTIS VENTURES

bidder

ARTIS VENTURES

WRVI CAPITAL

bidder

WRVI CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - GreatPoint Ventures led a $60m funding round in Excision BioTherapeutics.